Email
Hospital Circular 17/2010
Date Issued: 30 July 2010
Distribution: Public Hospitals,
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals of changes to the Highly Specialised Drugs Program, effective 1 August 2010
Background
We have received recent advice from the Commonwealth Department of Health and Ageing regarding changes to the Highly Specialised Drugs Program, effective 1 August 2010.
ADDED DRUG
TOCILIZUMAB
| 9657G | Concentrate for injection 80mg in 4mL |
1 | $186.88 | Actemra | RO |
| 9658H | Concentrate for injection 200mg in 10mL |
1 | $467.20 | Actemra | RO |
| 9659J | Concentrate for injection 400mg in 20mL |
1 | $934.40 | Actemra | RO |
Public hospital authority required: Treatment of adult patients with severe active rheumatoid arthritis
ADDED CONDITION
INFLIXIMAB
| 9654D | Powder for I.V. infusion 100mg |
1 | $751.70 | Remicade | SH |
Public hospital authority required: Initial treatment of complex refractory fistulising Crohn disease.
ADDED ITEMS
RITONAVIR
| 9660K | Tablet 100mg | 30 | $37.92 | Norvir | AB |
Streamlined authority required: code 3418
VALGANCICLOVIR
| 9655E | Powder for oral solution 50mg (base) per mL |
1 | $415.89 | Valcyte | RO |
Streamlined authority required: codes 3420 and 3421
DELETED ITEM
DELAVIRADINE MESYLATE
| 5959W | Tablet 100mg | 360 | Rescriptor | PF |
Item discontinued by manufacturer.
AMENDED RESTRICTIONS and/or NOTES
ABATACEPT- 5605B
INFLIXIMAB - 5753T, 5757B, 5756Y
LENALIDOMIDE - 5783J, 5784K, 5785L, 5786M
RALTEGRAVIR POTASSIUM - 9523F
RITUXIMAB - 9544H
THALIDOMIDE - 9566L
Further information on the changes including the full restrictions can be found at Commonwealth/State Highly Specialised Drugs Program Guidelines website or Department of Health and Ageing website.
PRICE CHANGES
| Pack size | from | to | ||
|---|---|---|---|---|
AZITHROMYCIN |
||||
| 5616N | Tablet 600mg | 8 | $59.34 | $58.15 |
CYCLOSPORIN |
||||
| 5634M | Capsule 25mg | 30 | $39.98 | $39.17 |
| 5635N | Capsule 50mg | 30 | $84.20 | $81.51 |
| 5636P | Capsule 100mg | 30 | $169.46 | $166.09 |
DISODIUM PAMIDRONATE |
||||
| 5667G | Concentrated injection 15mg in 5mL | 1 | $54.64 | $53.55 |
| 5668H | Concentrated injection 30mg in 10mL | 1 | $109.28 | $107.10 |
| 5669J | Concentrated injection 60mg in 10mL | 1 | $218.56 | $214.18 |
| 5670K | Concentrated injection 90mg in 10mL | 1 | $327.84 | $321.28 |
| 5701C | Injection set 4x15mg with 4x5mL | 1 | $218.56 | $214.19 |
| 5702D | Injection set 2x30mg with 2x10mL | 1 | $218.56 | $214.19 |
| 5703E | Injection set 1x90mg with 1x10mL | 1 | $327.84 | $321.28 |
RALTEGRAVIR POTASSIUM |
||||
| 9523F | Tablet 400mg | 60 | $1,146.90 | $665.55 |
Maree Guyatt
Director
Integrated Care
Changes notified by hospital circular will be updated in the Guidelines on the Commonwealth/State Highly Specialised Drugs Program Guidelines website and the claim form amended.
